14 May 2019
PlexPCR® RespiVirus receives TGA clearance for sale in Australia
PlexPCR® RespiVirus received clearance from the Australian Therapeutic Goods Administration (TGA), bringing much needed workflow advantages in time for the...
3 May 2019
Study gauges impact of genotyping on gonorrhea treatment
Dr. Klausner, a clinical professor at UCLA, shares the details of his work with genotypic testing for ciprofloxacin susceptibility in...
24 April 2019
SpeeDx Close Series A Fundraising With Support From U.S. Venture Firm
SpeeDx announced further series A funding received by new investor partners, Northpond Ventures, LP – a U.S.-based, formative stage venture...
16 April 2019
SpeeDx and Cepheid announce test partnership
SpeeDx Pty, Ltd. announced an agreement with Cepheid to manufacture their market-leading ResistancePlus® tests for use on the GeneXpert System....
15 April 2019
SpeeDx trusted assay partner for Cepheid FleXible for the GeneXpert program
ResistancePlus® MG will be the first test available through Cepheid's FleXible cartridge program. This partnership will increase access for clinicians...
26 March 2019
SpeeDx joins Texas CoLab
SpeeDx have successfully started their U.S. journey by joining the Texas Health CoLab in Austin Texas. Chosen for its synergy...